Adrienne L Graves - Net Worth and Insider Trading

Adrienne L Graves Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Adrienne L Graves owns 4 companies in total, including IVERIC bio Inc (ISEE) , Akorn Inc (AKRXQ) , and TearLab Corp (TEAR) among others .

Click here to see the complete history of Adrienne L Graves’s form 4 insider trades.

Insider Ownership Summary of Adrienne L Graves

Ticker	Comapny	Transaction Date	Type of Owner
ISEE	IVERIC bio Inc	2018-12-12	director
AKRXQ	Akorn Inc	2019-05-09	director
TEAR	TearLab Corp	2016-06-24	director
		2023-07-10	director

Adrienne L Graves Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Adrienne L Graves Ownership Network

Ownership Network List of Adrienne L Graves

No Data

Ownership Network Relation of Adrienne L Graves

Adrienne L Graves Owned Company Details

What does IVERIC bio Inc do?

Who are the key executives at IVERIC bio Inc?

Adrienne L Graves is the director of IVERIC bio Inc. Other key executives at IVERIC bio Inc include SVP & COO Keith Westby , SVP & CFO and Treasurer David Francis Carroll , and Senior Vice President & CCO Christopher Paul Simms .

IVERIC bio Inc (ISEE) Insider Trades Summary

Over the past 18 months, Adrienne L Graves made no insider transaction in IVERIC bio Inc (ISEE). Other recent insider transactions involving IVERIC bio Inc (ISEE) include a net sale of 243,904 shares made by Keith Westby , a net sale of 128,049 shares made by David Francis Carroll , and a net sale of 19,457 shares made by Glenn Sblendorio .

In summary, during the past 3 months, insiders sold 0 shares of IVERIC bio Inc (ISEE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 391,410 shares of IVERIC bio Inc (ISEE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 391,410 shares.

IVERIC bio Inc (ISEE)'s detailed insider trading history can be found in Insider Trading Tracker table.

IVERIC bio Inc Insider Transactions

No Available Data

What does Akorn Inc do?

Who are the key executives at Akorn Inc?

Adrienne L Graves is the director of Akorn Inc. Other key executives at Akorn Inc include EVP Gen Counsel & Secretary Joseph Bonaccorsi , SVP & Finance & CAO Randall E. Pollard , and EVP & Chief Commercial Officer Jonathan Kafer .

Akorn Inc (AKRXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akorn Inc (AKRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akorn Inc (AKRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akorn Inc (AKRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akorn Inc Insider Transactions

No Available Data

What does TearLab Corp do?

Who are the key executives at TearLab Corp?

Adrienne L Graves is the director of TearLab Corp. Other key executives at TearLab Corp include 10 percent owner Cr Group L.p. , 10 percent owner Awm Investment Company, Inc. , and Chief Financial Officer John Y Caloz .

TearLab Corp (TEAR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TearLab Corp (TEAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TearLab Corp (TEAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TearLab Corp (TEAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

TearLab Corp Insider Transactions

No Available Data

What does Ocular Therapeutix Inc do?

Who are the key executives at Ocular Therapeutix Inc?

Adrienne L Graves is the director of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Medical Officer Rabia Gurses Ozden .

Ocular Therapeutix Inc (OCUL) Insider Trades Summary

Over the past 18 months, Adrienne L Graves made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 51,149 shares made by Antony C. Mattessich , a net sale of 21,358 shares made by Rabia Gurses Ozden , and a net sale of 19,121 shares made by Donald Notman .

In summary, during the past 3 months, insiders sold 0 shares of Ocular Therapeutix Inc (OCUL) in total and bought 930,851 shares, with a net purchase of 930,851 shares. During the past 18 months, 134,055 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,341,757 shares.

Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocular Therapeutix Inc Insider Transactions

No Available Data

Adrienne L Graves Mailing Address

Above is the net worth, insider trading, and ownership report for Adrienne L Graves. You might contact Adrienne L Graves via mailing address: 125 Stone Mountain Circle, Napa Ca 94558.

Discussions on Adrienne L Graves

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.